Buy me a coffee
Home › FDA recalls › Hydrocortisone Sodium Succinate for Injection
CLASS II · ModerateFDA

Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection

📅 Oct 1, 2026 · 📍 Nationwide
Recalling company
Zydus Pharmaceuticals (USA) Inc
Product
Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.
Reason
Failed Impurities/Degradation Specifications.
Classification
Class II – may cause temporary or medically reversible health consequences
Recall date
Oct 1, 2026
Reported
Oct 21, 2026
Distribution
Nationwide within the United States
Status
Ongoing
Quantity
70776 vials
Lot / codes
Lot #: LB00047A, LB00048A, Exp. Date 03/2028
Company location
Pennington, NJ
Recall type
Voluntary: Firm initiated
Recall number
D-0039-2027
Agency
U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0039-2027 in the FDA Enforcement Report. Also see FDA recall press releases.

If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.